Petro Giržado veterinarijos farmacijos vaistinė, IĮ - financials and debts
Company age: 35 y. 0 mo.
Petro Giržado veterinarijos farmacijos vaistinė - Company finances
|
EUR
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|
|
Financial data
|
||
| Sales revenue | 135,726 | 133,691 |
| Profit before tax | 14,358 | -7,965 |
| Net profit | 13,617 | -8,041 |
| Equity | 56,504 | 78,463 |
| Liabilities | 5,049 | 5,949 |
| Non-current assets | 3,156 | 29,505 |
| Current assets | 58,310 | 54,538 |
| Total assets | 61,466 | 84,043 |
|
Taxes paid
|
||
| STI taxes | 11,955 | 7,457 |
| Social insurance contributions | - | - |
|
Financial indicators
|
||
| Revenue change y/y | - | -1.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 22.2% | -9.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 24.1% | -10.2% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 10.0% | -6.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 10.6% | -6.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.1 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 125,289 | 123,411 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Petro Giržado veterinarijos farmacijos vaistinė - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2023-07-19 | 2023-07-20 | 987.12 |
| 2023-05-16 | 2023-05-30 | 27.87 |
| 2023-05-10 | 2023-05-11 | 27.87 |
| 2022-12-09 | 2022-12-13 | 55.60 |
Petro Giržado veterinarijos farmacijos vaistinė - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-02-28 | 2026-03-11 | 0.82 |
| 2025-11-27 | 2025-12-29 | 0.89 |
| 2025-08-21 | 2025-09-01 | 0.07 |
| 2025-07-25 | 2025-07-25 | 0.08 |
| 2024-11-26 | 2024-12-01 | 0.72 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Petro Giržado veterinarijos farmacijos vaistine, II (code 157530859) is an Individual Enterprise engaged in the retail sale of pharmaceutical products. In the latest financial year 2025, revenue was €133.7K, slightly below €135.7K in 2024, reflecting a 1.5% year-on-year decline. Profitability weakened materially: the company moved from a net profit of €13.6K in 2024 to a net loss of €8.0K in 2025, with the profit margin turning from 10.0% to -6.0%. Over the two-year period, the business remained revenue-generating but the earnings trend deteriorated in 2025. The balance sheet expanded, with total assets rising from €61.5K to €84.0K, supported by equity increasing to €78.5K. Liabilities remained low at €5.9K, and the equity ratio stood at 93.4%, indicating a highly capitalised structure. Long-term assets increased to €29.5K from €3.2K a year earlier. Asset turnover was 1.59x, and revenue per employee was €133.7K, while profit per employee was -€8.0K in 2025.